Starr, T. N. et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell 182, 12951310 (2020).<\/p>\n
CAS Article Google Scholar <\/p>\n
Baum, A. et al. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science 369, 10141018 (2020).<\/p>\n
ADS CAS Article Google Scholar <\/p>\n
Van Egeren, D. et al. Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein. PLOS ONE 16, e0250780 (2021).<\/p>\n
Article Google Scholar <\/p>\n
Abdool Karim, S. S. & de Oliveira, T. New SARS-CoV-2 variantsclinical, public health, and vaccine implications. N. Engl. J. Med. 6, 67 (2021).<\/p>\n
Google Scholar <\/p>\n
Davies, N. G. et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science https:\/\/doi.org\/10.1126\/science.abg3055<\/a> (2021).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n Tada, T. et al. Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies. bioRxiv https:\/\/doi.org\/10.1101\/2021.02.18.431897<\/a> (2021).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n Tegally, H. et al. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv https:\/\/doi.org\/10.1101\/2020.12.21.20248640<\/a> (2020).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n Sabino, E. C. et al. Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence. The Lancet 397, 452455 (2021).<\/p>\n CAS Article Google Scholar <\/p>\n Kemp, S. A. et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature https:\/\/doi.org\/10.1038\/s41586-021-03291-y<\/a> (2021).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n Choi, B. et al. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host. N. Engl. J. Med. 383, 22912293 (2020).<\/p>\n Article Google Scholar <\/p>\n Valesano, A. L. et al. Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts. bioRxiv https:\/\/doi.org\/10.1101\/2021.01.19.427330<\/a> (2021).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n Baang, J. H. et al. Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient. J. Infect. Dis. 223, 2327 (2021).<\/p>\n CAS Article Google Scholar <\/p>\n Truong, T. T. et al. Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity. medRxiv https:\/\/doi.org\/10.1101\/2021.02.27.21252099<\/a> (2021).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n Avanzato, V. A. et al. Case study: Prolonged infectious SARS-CoV-2 Shedding from an asymptomatic immunocompromised individual with cancer. Cell 183, 1901-1912.e9 (2020).<\/p>\n CAS Article Google Scholar <\/p>\n Rueca, M. et al. Compartmentalized replication of SARS-Cov-2 in upper vs. lower respiratory tract assessed by whole genome quasispecies analysis. Microorganisms 8, 66 (2020).<\/p>\n Article Google Scholar <\/p>\n Ramazzotti, D. et al. VERSO: A comprehensive framework for the inference of robust phylogenies and the quantification of intra-host genomic diversity of viral samples. Patterns 2, 100212 (2021).<\/p>\n Article Google Scholar <\/p>\n Jary, A. et al. Evolution of viral quasispecies during SARS-CoV-2 infection. Clin. Microbiol. Infect. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.032<\/a> (2020).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n Capobianchi, M. R. et al. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy. Clin. Microbiol. Infect. 26, 954956 (2020).<\/p>\n CAS Article Google Scholar <\/p>\n Armero, A., Berthet, N. & Avarre, J.-C. Intra-host diversity of SARS-Cov-2 should not be neglected: Case of the state of Victoria, Australia. Viruses 13, 133 (2021).<\/p>\n CAS Article Google Scholar <\/p>\n Xu, Y. et al. Dynamics of severe acute respiratory syndrome coronavirus 2 genome variants in the feces during convalescence. J. Genet. Genomics 47, 610617 (2020).<\/p>\n Article Google Scholar <\/p>\n Popa, A. et al. Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Sci. Transl. Med. 12, 66 (2020).<\/p>\n Article Google Scholar <\/p>\n Lythgoe, K. A. et al. SARS-CoV-2 within-host diversity and transmission. Science https:\/\/doi.org\/10.1126\/science.abg0821<\/a> (2021).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n Pfefferle, S. et al. SARS Coronavirus-2 variant tracing within the first Coronavirus Disease 19 clusters in northern Germany. Clin. Microbiol. Infect. 27(130), e5-130.e8 (2021).<\/p>\n Google Scholar <\/p>\n James, S. E. et al. High resolution analysis of transmission dynamics of Sars-Cov-2 in two major hospital outbreaks in South Africa leveraging intrahost diversity. medRxiv https:\/\/doi.org\/10.1101\/2020.11.15.20231993<\/a> (2020).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n Shen, Z. et al. Genomic diversity of severe acute respiratory syndrome-coronavirus 2 in patients with coronavirus disease 2019. Clin. Infect. Dis. 71, 713720 (2020).<\/p>\n CAS Article Google Scholar <\/p>\n Wang, D. et al. Population bottlenecks and intra-host evolution during human-to-human transmission of SARS-CoV-2. Front. Med. 8, 66 (2021).<\/p>\n ADS CAS Google Scholar <\/p>\n Goyal, A., Reeves, D. & Schiffer, J. T. Early super-spreader events are a likely determinant of novel SARS-CoV-2 variant predominance. medRxiv https:\/\/doi.org\/10.1101\/2021.03.23.21254185<\/a> (2021).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n Wlfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465469 (2020).<\/p>\n ADS Article Google Scholar <\/p>\n Focosi, D. & Maggi, F. Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines. Rev. Med. Virol. https:\/\/doi.org\/10.1002\/rmv.2231<\/a> (2021).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n Grint, D. J. et al. Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February. Euro Surveill 26, 66 (2021).<\/p>\n Article Google Scholar <\/p>\n Grabowski, F., Preibisch, G., Giziski, S., Kochaczyk, M. & Lipniacki, T. SARS-CoV-2 variant of concern 202012\/01 has about twofold replicative advantage and acquires concerning mutations. Viruses 13, 66 (2021).<\/p>\n Article Google Scholar <\/p>\n Cele, S. et al. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. Nature https:\/\/doi.org\/10.1038\/s41586-021-03471-w<\/a> (2021).<\/p>\n Article PubMed Google Scholar <\/p>\n Wang, P. et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.. bioRxiv https:\/\/doi.org\/10.1101\/2021.01.25.428137<\/a> (2021).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n Widera, M. et al. Bamlanivimab does not neutralize two SARS-CoV-2 variants carrying E484K in vitro. medRxiv https:\/\/doi.org\/10.1101\/2021.02.24.21252372<\/a> (2021).<\/p>\n Article Google Scholar <\/p>\n Shen, X. et al. Neutralization of SARS-CoV-2 variants B.1.429 and B.1.351. N. Engl. J. Med. 6, 66 (2021).<\/p>\n Google Scholar <\/p>\n Garcia-Beltran, W. F. et al. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. medRxiv https:\/\/doi.org\/10.1101\/2021.02.14.21251704<\/a> (2021).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n Madhi, S. A. et al. Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant. N. Engl. J. Med. 6, 66 (2021).<\/p>\n Google Scholar <\/p>\n Kissler, S. M. et al. Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2. medRxiv https:\/\/doi.org\/10.1101\/2021.02.16.21251535<\/a> (2021).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n Domingo, E. & Perales, C. Viral quasispecies. PLoS Genet 15, e1008271 (2019).<\/p>\n CAS Article Google Scholar <\/p>\n CDC. COVID-19 Quarantine and Isolation. Centers for Disease Control and Prevention https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/your-health\/quarantine-isolation.html<\/a> (2021).<\/p>\n CDC. Ending Isolation and Precautions for People with COVID-19: Interim Guidance. Centers for Disease Control and Prevention https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/duration-isolation.html<\/a> (2021).<\/p>\n Marks, M. et al. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: A cohort study. Lancet Infect. Dis. 6, 66 (2021).<\/p>\n Google Scholar <\/p>\n CDC. COVID-19 and Your Health. Centers for Disease Control and Prevention https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/if-you-are-sick\/end-home-isolation.html<\/a> (2020).<\/p>\n van Kampen, J. J. A. et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat. Commun. 12, 267 (2021).<\/p>\n Article Google Scholar <\/p>\n La Scola, B. et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur. J. Clin. Microbiol. Infect. Dis. https:\/\/doi.org\/10.1007\/s10096-020-03913-9<\/a> (2020).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n Rhee, C., Kanjilal, S., Baker, M. & Klompas, M. Duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity: When is it safe to discontinue isolation?. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa1249<\/a> (2020).<\/p>\n Article PubMed Central Google Scholar <\/p>\n Rodrguez-Grande, C. et al. Inference of active viral replication in cases with sustained positive reverse transcription-PCR results for SARS-CoV-2. J. Clin. Microbiol. 59, 66 (2021).<\/p>\n Article Google Scholar <\/p>\n Dimcheff, D. E. et al. SARS-CoV-2 total and subgenomic RNA viral load in hospitalized patients. medRxiv https:\/\/doi.org\/10.1101\/2021.02.25.21252493<\/a> (2021).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n Lavine, J. S., Bjornstad, O. N. & Antia, R. Immunological characteristics govern the transition of COVID-19 to endemicity. Science 371, 741745 (2021).<\/p>\n ADS CAS Article Google Scholar <\/p>\n Herbeck, J. T. et al. Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission. AIDS 26, 193205 (2012).<\/p>\n Article Google Scholar <\/p>\n Watanabe, T. & Kawaoka, Y. Pathogenesis of the 1918 pandemic influenza virus. PLoS Pathog. 7, 66 (2011).<\/p>\n Google Scholar <\/p>\n Marshall, I. D. & Fenner, F. Studies in the epidemiology of infectious myxomatosis of rabbits. V. Changes in the innate resistance of Australian wild rabbits exposed to myxomatosis. J. Hyg. (Lond.) 56, 288302 (1958).<\/p>\n <\/p>\n Read more: <\/p>\n Controlling long-term SARS-CoV-2 infections can slow viral evolution and reduce the risk of treatment failure | Scientific Reports - Nature.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Starr, T. N. et al. Continue reading